Business Development • Strategic Management • Marketing • Branding • Reporting • Graphic Design • Project Management • HTML • CSS • Microsoft SQL • Final Cut Pro
Resumes
Enterprise Account Executive - Federal Aerospace And Defense
Feb 2013 to 2000 Business Development and Marketing ManagerDMC Companies, Fairfax Surf Shop, Virginia
2010 to 2000 ManagerDMC Companies
2005 to 2010 Sales Representative
Education:
George Mason University Fairfax, VA 2007 to 2011 Bachelor of Science in Business
Skills:
Business Development, Strategic Management, Marketing, Branding, Reporting, Graphic Design, Project Management, HTML, CSS, Microsoft SQL, Final Cut Pro
Dr. Rust graduated from the Temple University School of Medicine in 2010. He works in Beaver, PA and specializes in Internal Medicine and Urgent Care Medicine. Dr. Rust is affiliated with Heritage Valley Health System Beaver.
Fresh human pancreas tissue can be used as a source of cells whence to identify and select a non-stem cell population that is predisposed to be a source for surrogate pancreatic cells that can be used in treating insulin-dependent diabetes. The progenitors of these surrogate pancreatic cells have no reprogramming genes integrated into their genomes, differentiate to the pancreatic lineage pursuant to a protocol that employs only defined reagents, and are substantially unable to differentiate to the mesodermal lineage.
Pancreatic Cells For Treating Diabetes And Methods Of Generating The Same
- Germantown MD, US William L. Rust - Germantown MD, US
Assignee:
Seraxis, Inc. - Germantown MD
International Classification:
A61K 35/39 C12N 5/071
Abstract:
The present disclosure provides cell-based compositions for treating diabetes, methods for identifying cells that preferentially differentiate into endoderm cells, and methods for preparing insulin-producing pancreatic cells, as well as related methods of use for treating diseases related to insulin deficiency.
Pancreatic Cells For Treating Diabetes And Methods Of Generating The Same
- Germantown MD, US William L. Rust - Germantown MD, US
Assignee:
Seraxis, Inc. - Germantown MD
International Classification:
A61K 35/39 C12N 5/071
Abstract:
The present disclosure provides cell-based compositions for treating diabetes, methods for identifying cells that preferentially differentiate into endoderm cells, and methods for preparing insulin-producing pancreatic cells, as well as related methods of use for treating diseases related to insulin deficiency.
Macro-Encapsulated Therapeutic Cells, Devices, And Methods Of Using The Same
- Germantown MD, US William L. Rust - Germantown MD, US
Assignee:
Seraxis, Inc. - Germantown MD
International Classification:
A61L 31/08 A61P 3/10 A61K 35/39 A61L 31/04
Abstract:
Described are macro-capsules, barriers, and devices that can be used to prepare therapeutic cell implants, methods of encapsulating therapeutic cells, and methods of using the encapsulated cells in the treatment of disease.
Macro-Encapsulated Therapeutic Cells And Methods Of Using The Same
Described are macro-capsules and barriers that can be used to prepare therapeutic cell implants, methods of encapsulating therapeutic cells, and methods of using the encapsulated cells in the treatment of disease.
Stem Cells And Pancreatic Cells Useful For The Treatment Of Insulin-Dependent Diabetes Mellitus
- Germantown MD, US William L. Rust - Germantown MD, US
Assignee:
Seraxis, Inc. - Germantown MD
International Classification:
A61K 35/39 C12N 5/071
Abstract:
Fresh human pancreas tissue can be used as a source of cells whence to identify and select a non-stem cell population that is predisposed to be a source for surrogate pancreatic cells that can be used in treating insulin-dependent diabetes. The progenitors of these surrogate pancreatic cells have no reprogramming genes integrated into their genomes, differentiate to the pancreatic lineage pursuant to a protocol that employs only defined reagents, and are substantially unable to differentiate to the mesodermal lineage.